Blue Bees Therapeutics
Pre-clinicalBlue Bees Therapeutics develops immunomodulatory proteins with therapeutic potential to fight cancer
Founded
2022
Focus
Biologics
About
Blue Bees Therapeutics develops immunomodulatory proteins with therapeutic potential to fight cancer
Company Info
TypePrivate
Founded2022
LocationParis, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile